A Phase II Study of MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube or Peritoneal Cancer - Stand Up To Cancer

Blog

Posted October 14, 2019

A Phase II Study of MK2206 in the Treatment of Recurrent Platinum-Resistant Ovarian, Fallopian Tube or Peritoneal Cancer

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Please validate the captcha
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.